We hypothesize that changes in the gut microbiota in diabetic db/db mice (untreated and CKK- and PFD-treated) compared to lean db/m mice allow for insights into the role of gut microbes in diabetic nephropathy and potentially beneficial effects associated with PFD and CCK treatments. Here, CCK is linked to diabetic kidney disease.